[144] MetLife, Inc. SEC Filing

Rhea-AI Filing Summary

trivago N.V. filed a Form 6-K disclosing that on 31 July 2025 it closed the acquisition of Holisto Limited, an AI-driven hotel-rate aggregator and white-label booking-engine provider.

trivago purchased all remaining equity for ≈ €22.3 million (US$25.5 million); Holisto is now a wholly-owned, consolidated subsidiary. The deal brings 211 employees, a merchant-of-record capability for hotel bookings, and technology that complements trivago’s metasearch platform.

No financial performance metrics, funding details, or post-deal guidance were provided. Future results will include Holisto’s operations; integration execution and synergy capture are key uncertainties for investors.

Positive

• Strategic technology boost: AI-driven aggregation and merchant-of-record capabilities can expand revenue streams beyond metasearch CPC.
• Limited financial risk: €22.3 m purchase price is small relative to trivago’s market value and cash position, containing downside.

Negative

• Integration uncertainty: Success depends on effectively merging Holisto’s platform and workforce with trivago’s operations.
• No financial disclosure: Filing omits Holisto revenue, profitability, or projected synergies, making ROI assessment difficult.

Insights

M&A Specialist

TL;DR – Small, strategic tech tuck-in; limited near-term P&L impact.

The €22.3 m price tag suggests a modest 1–2 % of TRVG’s market cap, implying manageable balance-sheet risk. Holisto supplies full-stack booking and merchant-of-record functionality that can boost take-rate on direct bookings and de-risk dependence on metasearch CPC revenue. Consolidation should be straightforward given Holisto’s 211-person footprint, but value creation hinges on cross-selling and tech integration. Absent disclosed revenue or EBITDA, the accretion timeline is unclear, warranting a neutral impact rating.

Equity Analyst

TL;DR – Adds AI capability; watch for execution.

Strategically, AI-powered rate aggregation enhances user relevance and could bolster conversion, supporting TRVG’s pivot toward transaction-based revenue. However, lack of disclosed synergies, purchase-price allocation, or funding source limits visibility into ROI. Given modest deal size, dilution risk is negligible but upside is unquantified. Overall share-price impact likely muted until operational metrics show lift.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Goldman Sachs 200 West Street New York NY 10005	209	15631.11	671297826	07/31/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/21/2014	Purchase	DEUTSCHE BANK			150	03/26/2014	Cash
Common Stock	06/20/2014	Purchase	GOLDMAN SACHS			59	06/25/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	06/13/2025	221	17094.35
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	547	43327.87
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	360	28515.6
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	101	8000.21
Separate Account 149 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	27	2138.67
MetLife 401k Plan Trust 1 Metlife Way Whippany NJ 07981	Common Stock	06/27/2025	1024	82298.88
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	07/28/2025	360	27957.6

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)